Home » Psychology news » FDA approves new injectable drug to treat schizophrenia
FDA approves new injectable drug to treat schizophrenia
October 7, 2015 by NewsBot
On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia.
